A randomized controlled trial on the use of convalescent plasma therapy to treat coronavirus infections—the first in the world to be completed—yields disappointing results, but some doctors are not discouraged.

Researchers say the popularity of convalescent plasma makes it more difficult to gather high-quality data on its efficacy.

Under emergency protocols, doctors can request to use survivors’ plasma to treat some critically ill COVID-19 patients.